Episode 61: What underwriters are watching now and what it means for your cases

Join us for this month’s episode of Hancock Talks as Dr. Magdalena Kluchko, Chief Medical Director at John Hancock, shares her expert perspective on how ongoing changes in underwriting are reshaping risk assessment and influencing your cases. This conversation offers valuable insights to help you better understand underwriting decisions and enhance client outcomes.Tune in to learn:Smarter decisions: How underwriting is shifting from simple snapshots to a more complete, data-driven view of a client’s health. Key trends: What to know about GLP-1 medications, early detection tools, and other emerging medical developments. Producer tips: Practical ways to improve case outcomes through early collaboration and more complete medical information.Listen now to gain practical insights that can help you navigate today’s evolving underwriting landscape.Insurance products are issued by: John Hancock Life Insurance Company (U.S.A.), Boston, MA 02116 (not licensed in New York) and John Hancock Life Insurance Company of New York, Valhalla, NY 10595.MLINY062326187-2